Pfizer Secures Option to Acquire AM-Pharma

15-May-2015 - AM-Pharma B.V., and Pfizer Inc. announced that Pfizer has acquired a minority equity interest in AM-Pharma and secured an exclusive option to acquire the remaining equity in the company. The option becomes exercisable upon completion of a Phase II trial of recAP in the treatment of Acute Kidney ...

AM-Pharma presents positive Phase II results for potential First-In-Class drug

Alkaline Phosphatase improved renal function, reduced length of stay in Intensive Care, and could become First-in-Class drug in multi-billion market

15-Mar-2010 - AM-Pharma B.V. announced positive results from its Phase II Acute Kidney Injury trial with Alkaline Phosphatase. The study showed that treatment of Acute Kidney Injury (AKI) with Alkaline Phosphatase results in improved renal function and reduced length of stay in Intensive Care. No drug ...

AM-Pharma announces positive results from its Acute Kidney Injury trial

Positive Phase II trial results confirm observations from earlier Acute Kidney Injury trial

18-Dec-2009 - AM-Pharma B.V. announced positive results from its Phase II Acute Kidney Injury trial with Alkaline Phosphatase. AM-Pharma showed statistically significant improvement on the primary clinical endpoint and on several secondary endpoints after interim analysis of the treatment effect on 26 ...

AM-Pharma announces 2.5 million EURO financing

AM-Pharma financing kick-starts Series C financing effort

07-Aug-2007 - AM-Pharma B.V., a biopharmaceutical company developing improved endogenous proteins to combat disease, announced the signing of a 2.5 million Euro financing agreement with its two main investors, Forbion Capital Partners and Inventages Venture Capital. The investment is a prelude to a Series C ...

greenovation and AM-Pharma announce successful production of alkaline phosphatase in moss

25-Jul-2005 - greenovation Biotech GmbH and AM-Pharma B.V. announced today that they have completed a major milestone in the development of a new production system for the manufacture of human alkaline phosphatase in moss. AM-Pharma develops alkaline phosphatases of various origin to be used for the ...